Bruce E. Lewis MD , Dominick V. Bufalino MD , Mohammed H. Hussein MD , Sorcha Allen MBBCh, BAO , Lukas Burke MD , Rashad J. Belin MD, PhD , Marc G. Henderson RCIS , Jeffrey Schwartz MD
{"title":"经皮修复慢性主动脉假性动脉瘤:单中心经验","authors":"Bruce E. Lewis MD , Dominick V. Bufalino MD , Mohammed H. Hussein MD , Sorcha Allen MBBCh, BAO , Lukas Burke MD , Rashad J. Belin MD, PhD , Marc G. Henderson RCIS , Jeffrey Schwartz MD","doi":"10.1016/j.jscai.2024.102249","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Aortic pseudoaneurysm (AP) is a late complication of aortic repair that, without intervention, carries a high mortality rate. Surgical repair has significant in-hospital mortality and high health care costs. Endovascular stent grafting use is currently limited to branch-free aortic segments or the use of complex fenestrated devices. Our objective was to review the literature and share our institution’s experience with AP percutaneous closure by vascular plugs and occluder technology.</div></div><div><h3>Methods</h3><div>We retrospectively reviewed percutaneous AP closure cases published in the literature (2005-2016) and from our institution (2017-2019). The follow-up strategy in our institution group was up to the discretion of the performing physician. We measured the procedure’s safety, complications, and follow-up outcomes.</div></div><div><h3>Results</h3><div>We found 40 cases in the literature and 10 at our institution. The procedural success rate was 90% in the literature and 100% in our group. Our group’s average length of stay was 1.9 days with no observed major procedural complications. The literature’s follow-up was generally limited to the hospitalization period. Our patients had a median follow-up time of 12 months (range 3-47 months). Late follow-up of AP demonstrated that sac size remained stable or reduced in 6 patients, but a size increase was observed in 4 patients requiring surgical intervention. Death from nonprocedure-related complications occurred in 40% of our patients. The cost per procedure was hypothetically less than for performing open surgical repair.</div></div><div><h3>Conclusions</h3><div>Our experience shows a viable option for percutaneous AP repair, given its initial safety and cost-effectiveness. Our experience highlights the critical role of follow-up imaging in identifying AP expansion and the need for further intervention. The high nonaorta-related mortality seen in follow-up emphasizes the high-risk nature of the population due to comorbidities.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"3 10","pages":"Article 102249"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Percutaneous Repair of Chronic Aortic Pseudoaneurysm: A Single-Center Experience\",\"authors\":\"Bruce E. Lewis MD , Dominick V. Bufalino MD , Mohammed H. Hussein MD , Sorcha Allen MBBCh, BAO , Lukas Burke MD , Rashad J. Belin MD, PhD , Marc G. Henderson RCIS , Jeffrey Schwartz MD\",\"doi\":\"10.1016/j.jscai.2024.102249\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Aortic pseudoaneurysm (AP) is a late complication of aortic repair that, without intervention, carries a high mortality rate. Surgical repair has significant in-hospital mortality and high health care costs. Endovascular stent grafting use is currently limited to branch-free aortic segments or the use of complex fenestrated devices. Our objective was to review the literature and share our institution’s experience with AP percutaneous closure by vascular plugs and occluder technology.</div></div><div><h3>Methods</h3><div>We retrospectively reviewed percutaneous AP closure cases published in the literature (2005-2016) and from our institution (2017-2019). The follow-up strategy in our institution group was up to the discretion of the performing physician. We measured the procedure’s safety, complications, and follow-up outcomes.</div></div><div><h3>Results</h3><div>We found 40 cases in the literature and 10 at our institution. The procedural success rate was 90% in the literature and 100% in our group. Our group’s average length of stay was 1.9 days with no observed major procedural complications. The literature’s follow-up was generally limited to the hospitalization period. Our patients had a median follow-up time of 12 months (range 3-47 months). Late follow-up of AP demonstrated that sac size remained stable or reduced in 6 patients, but a size increase was observed in 4 patients requiring surgical intervention. Death from nonprocedure-related complications occurred in 40% of our patients. The cost per procedure was hypothetically less than for performing open surgical repair.</div></div><div><h3>Conclusions</h3><div>Our experience shows a viable option for percutaneous AP repair, given its initial safety and cost-effectiveness. Our experience highlights the critical role of follow-up imaging in identifying AP expansion and the need for further intervention. The high nonaorta-related mortality seen in follow-up emphasizes the high-risk nature of the population due to comorbidities.</div></div>\",\"PeriodicalId\":73990,\"journal\":{\"name\":\"Journal of the Society for Cardiovascular Angiography & Interventions\",\"volume\":\"3 10\",\"pages\":\"Article 102249\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the Society for Cardiovascular Angiography & Interventions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772930324016314\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Society for Cardiovascular Angiography & Interventions","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772930324016314","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景主动脉假性动脉瘤(AP)是主动脉修补术的晚期并发症,如不进行干预,死亡率很高。手术修复的院内死亡率很高,医疗费用也很高。目前,血管内支架移植仅限于无分支的主动脉段或使用复杂的栅栏式装置。我们的目的是回顾文献,并分享我院使用血管栓塞和闭塞器技术经皮闭合 AP 的经验。方法我们回顾了文献中发表的经皮闭合 AP 病例(2005-2016 年)和我院的病例(2017-2019 年)。我院组的随访策略由手术医生自行决定。我们对手术的安全性、并发症和随访结果进行了测量。文献中的手术成功率为 90%,我院的手术成功率为 100%。我们小组的平均住院时间为 1.9 天,未发现重大手术并发症。文献中的随访一般仅限于住院期间。本组患者的中位随访时间为 12 个月(3-47 个月)。对 AP 的后期随访显示,有 6 名患者的囊大小保持稳定或缩小,但有 4 名患者的囊大小增大,需要进行手术干预。40%的患者死于与手术无关的并发症。结论:我们的经验表明,鉴于经皮 AP 修复术最初的安全性和成本效益,它是一种可行的选择。我们的经验强调了随访成像在识别 AP 扩大和进一步干预需求方面的关键作用。随访中发现的非主动脉相关死亡率很高,这强调了该人群因合并症而具有的高风险性。
Percutaneous Repair of Chronic Aortic Pseudoaneurysm: A Single-Center Experience
Background
Aortic pseudoaneurysm (AP) is a late complication of aortic repair that, without intervention, carries a high mortality rate. Surgical repair has significant in-hospital mortality and high health care costs. Endovascular stent grafting use is currently limited to branch-free aortic segments or the use of complex fenestrated devices. Our objective was to review the literature and share our institution’s experience with AP percutaneous closure by vascular plugs and occluder technology.
Methods
We retrospectively reviewed percutaneous AP closure cases published in the literature (2005-2016) and from our institution (2017-2019). The follow-up strategy in our institution group was up to the discretion of the performing physician. We measured the procedure’s safety, complications, and follow-up outcomes.
Results
We found 40 cases in the literature and 10 at our institution. The procedural success rate was 90% in the literature and 100% in our group. Our group’s average length of stay was 1.9 days with no observed major procedural complications. The literature’s follow-up was generally limited to the hospitalization period. Our patients had a median follow-up time of 12 months (range 3-47 months). Late follow-up of AP demonstrated that sac size remained stable or reduced in 6 patients, but a size increase was observed in 4 patients requiring surgical intervention. Death from nonprocedure-related complications occurred in 40% of our patients. The cost per procedure was hypothetically less than for performing open surgical repair.
Conclusions
Our experience shows a viable option for percutaneous AP repair, given its initial safety and cost-effectiveness. Our experience highlights the critical role of follow-up imaging in identifying AP expansion and the need for further intervention. The high nonaorta-related mortality seen in follow-up emphasizes the high-risk nature of the population due to comorbidities.